Rod Windley, PSA's Chairman, said: "Both Innovations and Assure are terrific companies that enjoy excellent clinical reputations in their respective markets. Innovations complements PSA's existing geographic reach by providing a strong market presence in East Texas while the San Antonio offices of both Innovations and Assure give us a meaningful presence in the San Antonio market. Texas is a tremendous growth opportunity for PSA and we are continuing to build density throughout the state."
Matt Strange, CEO of Assure, said: "We are thrilled to be joining the PSA family and we could not find a better cultural fit for our company. We see a bright future for our patients and our company as part of PSA."
David Metcalf, President of Innovations, who will join the PSA management team in Texas going forward, stated: "We are excited to be part of such a groundbreaking and growing company with a very steep upward trajectory. For me personally, I am delighted to be able to continue to serve our patients and work with our teammates as a member of the PSA management team."
With the addition of Innovations' office in Tyler and the San Antonio offices of both Innovations and Assure, PSA now has 12 offices serving the attractive Texas market, with further expansion in the state expected in the future.
Edge Healthcare Partners served as PSA's financial advisor.
About PSA Healthcare
Based in Atlanta, Ga., PSA Healthcare has been a recognized leader in pediatric and adult home care for more than 30 years. PSA has more than 75 locations in 16 states, including Florida, Georgia, Pennsylvania, Colorado, Texas and Louisiana. A privately owned company, PSA is dedicated to providing Trusted Care with compassion, quality, and clinical excellence. For more information, visit www.psahealthcare.com.
Thomas Davies (212) 521-4873
Ross Lovern (212) 521-4876
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/psa-healthcare-announces-acquisitions-of-innovations-health-services-and-assure-home-healthcare-300358312.html
SOURCE PSA Healthcare